Form 4: USANA Health Sciences Director Trades USNA Stock

USANA Health Sciences Director Ding Xia reported transactions involving common stock and restricted stock units.

Summary

• Director Ding Xia of USANA Health Sciences Inc. (USNA) engaged in stock transactions on April 23, 2026.
• Xia acquired 1,057 shares of common stock.
• Xia also disposed of 391 shares of common stock at a price of $19.24 per share.
• Following these transactions, Xia beneficially owns 7,641 shares of common stock directly.
• The filing also details the vesting schedule for Restricted Stock Units (RSUs), with 25% vesting on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions with both acquisitions and dispositions, balanced by the clear disclosure of RSU vesting.

Positives

• Director acquired 1,057 shares of common stock, indicating potential confidence in the company.
• The vesting schedule for RSUs is clearly defined, providing transparency for future share issuances.

Negatives

• Director disposed of 391 shares of common stock, which could be interpreted as a reduction in direct ownership.

Future Outlook

The vesting schedule for Restricted Stock Units indicates future potential share issuances on specific dates in 2025 and 2026.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the health sciences and direct selling industry, providing transparency to the market regarding executive and director stock activity.

Stakeholder Impact

• Shareholders: Increased transparency into director's stock holdings and transactions.

Next Steps

• Vesting of remaining Restricted Stock Units on scheduled dates.

Key Dates

Keywords

USANA Health Sciences, USNA, Form 4, Insider Trading, Stock Transaction, Director, Restricted Stock Units, Beneficial Ownership